FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' lisinopril supplemental application (ANDA 075903), making a generic lisinopril tablet available with approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)